Connect with us

EU

#Romania: Leading businessman Dan Adamescu dies in prison

Avatar

Published

on

Foto Dan Adamescu bw(1)Leading Romanian businessman Dan Adamescu (pictured) has become the latest victim of Romania’s “failing” penal and judicial system.

Adamescu was serving a four year sentence for alleged bribery but had been seriously ill for some time and died in a hospital in Bucharest, aged 68.

A leading campaign group says Adamescu should have been released from prison both on health and age grounds and the case highlights a “total breakdown in the rule of law” in the country.

Willy Fautre, director of the Brussels-based NGO Human Rights Without Frontiers (HRWF), says the EU has an important role in such matters and  should “closely monitor” the situation in Romania.

He told this website: “This is not an isolated case. I was in Romania last week and personally saw the huge public demonstrations about this issue.”

Adamescu, whose fortune was estimated by Forbes at €550m, had asked judges in late 2016 to let him get out of jail sooner because of his age and due to the fact that he was already investigated while in preventive arrest. However, the court rejected his request.

A German citizen of Romanian origin, he founded the Nova Group (TNG), which holds stakes in Romanian real estate like the InterContinental Hotel Bucharest and Unirea Shopping Centre.

In May 2014,he was imprisoned and sentenced to four years and four months on charges of bribery and corruption after what is widely seen as a show trial in February 2015. He vehemently denied the accusation and his family now say that the conditions in which he was held, and lack of medical care afforded to him, contributed to his death.

His son, Alexander Adamescu, has been fighting to clear his father’s name, says he has also become a target for the Romanian authorities who are requesting his extradition and incarceration.

London-based Alexander said: “My sadness at this time is tinged with anger directed towards the Romanian state, whose persecution of my father caused his death. My father was vilified, haunted and assassinated to satisfy Romania’s thirst for trophies in its ill-conceived anti-corruption mania. Now my turn has come to face the same fate. The trial and imprisonment on trumped-up charges left my father facing not only a justice system which blatantly failed to guarantee him a fair trial but also a prison system which is in breach of fundamental human rights.”

Fautre, whose organization highlights human rights abuses around the world, said Adamescu’s death while in detention “sheds once again some tragic light on the appalling prison conditions” in Romania which, he says, have been denounced “year after year” by the European Court of Human Rights.

He said “negative reports” on the state of the penal and judicial system in Romania have also been issued since 2013 by the Strasbourg-based Council of Europe’s Committee of Prevention of Torture and the U.S State Department.

Similar concern has been expressed by Romania’s Ombudsman in his 2015 report.

Fautre added: “Adamescu was known to be in very bad health but his requests for an early release were disregarded by the authorities. Prisons are overcrowded in Romania: eight of them have an occupancy rate of over 200%, and the average occupancy rate in local prisons is of some 150%.”

If Romania does not solve the problems,  the European Court of Human Rights has said it will rule that the country – a member of the European Union - must pay compensations to all inmates for each day of detention in improper conditions.

These compensations would amount to some € 80 million per year.

Fautre went on: “Given his condition, Adamescu should not have been kept in detention and our NGO considers that the EU should closely monitor the respect of fundamental human rights in Romania.”

According to research, Romania is the European country with the highest number of its expats in prison in the EU (11,511).

In July 2016, prison protests spread across Romania as inmates expressed their dissatisfaction with poor conditions.

Romanian jails still fall below European standards, with overcrowding, inadequate medical attention and poor diet remain the main problems, according to activists. Its jails are said to still have inadequate hygiene conditions, with insufficient access to warm water, insufficient sanitary facilities, insufficient natural lighting and ventilation, and poor food quality.

A Council of Europe source said: "The Adamescu case illustrates the failing penal and judicial system in Romania."

Alexander Adamescu says that, despite his failing health, his father fought “injustices to the end”.

He added: “As a family, we are determined to continue the fight to make the truth know, restore his legacy and bring an end to the oppression of basic freedoms in Romania.”

EU

Last chance to register for EAPM EU Presidency Conference

Avatar

Published

on


Hello, health colleagues, and welcome to the European Alliance for Personalised Medicine (EAPM) update – we are looking forward very much to the 9th EU Presidency Conference, under the auspices of the Portuguese EU Presidency, which takes place online on Monday, 8 March from 9-16h CET – the aim of the game is all about establishing a health policy framework across the EU, writes EAPM Executive Director Denis Horgan.

EU Presidency Conference
The EAPM conference will feature a wide range of keynote speakers from across the EU, including Christine Chomienne, vice chairwoman of the Mission Board Cancer at the European Commission and professor of Cellular Biology at the Université deParis, France, MEP Pernille Weiss, and Daria Julkowska, co-ordinator of the European Joint Programme on Rare Diseases.

In terms of the themes undertaken by the conference, these will include propelling health care through an effective governance framework, and update on the Europe Beating Cancer Plan, and the role of biomarkers and advanced molecular diagnostics.

Health-care systems are not always ready to respond to the opportunities. The disruptive nature of personalised care challenges traditional patterns of thinking. Practices, presumptions and even prejudices that date from before the millennium resist a 21st century approach to healthcare.

The conference will be seeking to move towards establishing a policy framework, in order to realize the potential of personalised health care, and not only in Europe: Europe’s engagement in global research and scientific enterprise can benefit the population of the entire planet.

As far as the conference is concerned, it is absolutely clear that it is necessary to formulate a personalised healthcare-centred strategy involving decision makers and regulators in the arena of public health, to enable the EU and member states to contribute to integrating personalised medicine into clinical practicewhile enabling much-greater access for patients.

For the opening session, which is entitled propelling health care through an effective governance framework, at the start of the 2020s, wide-ranging changes are under way in European society and governance, with a new European Commission, a freshly-elected European Parliament, and a growing conviction among Europe’s policymakers that people must be at the centre of any successful and sustainable strategy. The ambition of new Commission President Ursula von der Leyen is a Europe that ‘must lead the transition to a healthy planet and a new digital world’. And Health Commissioner Stella Kyriakides acknowledges that “European citizens expect the peace of mind that comes with access to health care… and protection against epidemics and diseases.”

The second session deals with the EU’s Beating Cancer Plan, and the conference will examine the new technologies, research and innovation that the Cancer Plan is taking as a starting point, in terms of setting out a new EU approach to cancer prevention, treatment and care.

Europe's Beating Cancer Plan will be supported by actions spanning across policy areas from employment, education, social policy and equality, through marketing, agriculture, energy, the environment and climate, to transport, cohesion policy, and taxation. A total of €4 billion is being earmarked for actions addressing cancer, including from the EU4Health programme, Horizon Europe and the Digital Europe programme. Expectations have been heightened by European strategists’ attachment to three key ingredients for courageous transformation: incentives, innovation, and investment. These reflect the pre-conditions for boosting health care into higher levels of efficiency, where the value of personalised medicine approaches can be fully appreciated and make its full contribution to Europe’s citizens.

This discussion of personalised health-care depicts a Europe where many chances for improvement are not yet fully being taken up. But this is not merely a catalogue of deficiencies. The variations and inefficiencies it presents are an argument for triggering radical rethinking, and for making the most of personalised health care. It highlights the endorsement of incentives, innovation, and investment by a new breed of Europe’s leaders. And it focuses on the ambitions that would support the development of personalised health care, diagnostics and medicines.

Everyone - from newborn babies to the elderly, from sufferers from chronic disease to acute cancer patients, and from health ministries to funding agencies - stands to gain. The price is nothing more than a shift in policy. The prize – in terms of value to the economy and to lives - is priceless.

As far as the role of biomarkers and advanced molecular diagnostics is concerned, the conference will also deal with this important subject in a latter session - today, biomarkers have immense scientific and potential clinical value in the diagnostic testing pipeline. They span the broad diagnostic sector from the genome to the phenome over various ‘-ome’ levels and have been used since the earliest days of the application of molecular biology. A biomarker signature is capable of revealing specific biological traits or measurable physiological changes, according to a disease status, physiological or pathological condition, or after drug application.

An understanding of biomarkers ties in to the existing new understanding of epidemiology, precision medicine, and pharmacogenomics, the deployment of technologies such as genomics, single cell sequencing, microbiome analysis and transcriptomics, and the opportunities arising from bioinformatics and digital innovations, which can be transformative for individual patients.

As novel gene-based diagnostics proliferate, they will be increasingly important to drug development, approval and later in clinical practice. There are numerous promising singular biomarkers or more complex multiple biomarker signatures available, the most important of which are currently used for assessing drug development, patient stratification or measuring the efficacy of treatment in therapeutic medicine. Clearly there is a translation problem to transfer the results from molecular diagnostics research to drug development and finally clinical practice. In future, biomarkers and their interaction on various levels will increase the molecular and cellular knowledge of disease and drug mechanisms.

To register for the conference, click here and click here for the agenda.

Von der Leyen proposes EU-wide health passport

The European Commission will present legislation for a digital health pass before the end of March. The announcement follows a virtual meeting between EU leaders last week, where Greece and Austria urged other states to adopt vaccination passports in order to restart travel and tourism. However, others remain on the fence due to concerns over vaccine efficacy and discrimination. Following the discussion of vaccines and travel restrictions by EU leaders during the European Council video conference, the bloc is taking further steps to reintroduce travel across the continent. European Commission President Ursula von der Leyen said in a tweet that legislation is being prepared for a ‘Digital Green Pass’. This will serve to provide proof of vaccination, test-results for “those who couldn’t get vaccine yet”, or information on COVID-19 recovery.

Von der Leyen, who has been the Commission’s president since December 2019, said that the digital pass was needed to facilitate Europeans’ lives. The proposal, she said, will be finalized and presented before the end of March.

That is everything for this week from EAPM – remember, registration is still open for the EU Presidency conference but only until the end of today (5 March) – 150 people have already signed up, click here to register and join them, and click here for the agenda. To those who will attend, EAPM looks forward very much to joining them on 8 March – stay safe and well, and have an excellent weekend.

Continue Reading

China

EU ready to take further steps if China amends Hong Kong's electoral laws

EU Reporter Correspondent

Published

on

In response to an announcement by the National People's Congress in China that it would deliberate on amending the electoral system of the Hong Kong Special Administrative Region, the European External Action Service issued a statement saying: "If enacted, such reform would have potentially far-reaching negative consequences for democratic principles and democratically elected-representatives in Hong Kong. It would also run counter to previous electoral reforms in Hong Kong and renege on the commitments enshrined in Articles 45 and 68 of the Basic Law to introduce universal suffrage in the elections of the Chief Executive and Legislative Council.

"The EU calls on the authorities in Beijing to carefully consider the political and economic implications of any decision to reform the electoral system of Hong Kong that would undermine fundamental freedoms, political pluralism and democratic principles. As agreed by EU Foreign Ministers, the EU stands ready to take additional steps in response to any further serious deterioration of political freedoms and human rights in Hong Kong, which would be against China’s domestic and international obligations."

A decision can be expected by 11 March.

Continue Reading

Brexit

Fishing firms could go bust over Brexit, MPs told

Guest contributor

Published

on

British fishing businesses could go bust or move to Europe because of post-Brexit trading disruption, industry figures have warned, writes the BBC.

MPs were told paperwork due to new border controls had proved a "massive problem" and should be moved online.

They also heard extra costs had made it "impossible" for some firms to trade profitably.

Ministers have promised action on disruption, and £23 million for affected firms.

The UK government has also set up a taskforce aiming to resolve problems faced by the industry in Scotland.

The Commons environment committee heard funding could have to continue, and be widened further, to help the sector weather Brexit-related problems.

Outside the EU's single market, British fish exports to Europe are now subject to new customs and veterinary checks which have caused problems at the border.

Martyn Youell, a manager at south-west England fishing company Waterdance, told MPs the industry was facing more than just "teething problems".

"Whilst some things have settled down, some obvious issues, we feel that we remain with at least 80% of the trading difficulties that have been encountered," he said.

"There are some extreme forces operating on the supply chain, and we probably will see some forced consolidation or business failure."

"The exporters we deal with are seriously considering relocating part of their processing business to the EU because of the difficulties we face".

He said the "largely paper-based" forms they now have to fill in had pushed up costs, and called for the UK to work with the EU in moving them online.

'Lot of anger'

Donna Fordyce, chief executive of Seafood Scotland, said the problems could lead to smaller firms in particular stopping trading with Europe in the medium term.

She said the annual costs of the new paperwork, between £250,000 and £500,000 per year, were too much for them to sustain.

But she said many "can't see where they could turn" at the moment because travel bans and the Covid pandemic have closed off other markets.

She added there was "a lot of anger" about the design of the government's £23m compensation scheme, which links funds to provable losses due to Brexit.

She said it meant many firms which had "worked through the night" to get shipments ready had not been compensated for extra costs.

Shellfish ban

Sarah Horsfall, co-chief executive at the Shellfish Association of Great Britain, also criticised the scheme, noting firms that "made massive efforts" didn't qualify.

She also called for ministers to adopt a different approach to persuade the EU to overturn a ban on British exports of some types of live shellfish.

After leaving the EU single market, these exports from all but the highest-grade fishing grounds have to be purified before they can enter the EU market.

The UK government has accused the EU of reneging on a previous commitment such exports could continue with a special certificate.

Ms Horsfall said there had been the "propensity for a bit of a misunderstanding" among either UK or EU officials about the post-Brexit rules.

She urged a "more nuanced approach" from UK ministers in resolving the matter, noting their "bullish" response "perhaps hasn't helped either".

And she said a more "flexible" regime for determining the quality of British fishing waters could provide help to the industry in the long-term.

Continue Reading

Twitter

Facebook

Trending